. He can be reached at nsaraceno@mjhlifesciences.com.

Articles

The industry veteran will lead the company’s next phase of growth, focusing on faster treatment initiation through integrated digital platforms and optimized fulfillment strategies.

Knipper Health Taps Willis Chandler as New President and CEO

The agreement grants LEO Pharma exclusive rights to the branded form of spesolimab for generalized pustular psoriasis and potentially, other IL-36–driven conditions.

LEO Pharma to Head Global Commercialization of Spevigo in $105M Deal with Boehringer Ingelheim

Videos

In the first part of his Pharma Commerce video interview, Murray Aitken, executive director, IQVIA Institute for Human Data Science, describes the process behind developing the “Global Use of Medicines Outlook Through 2029” report.

From Data to Insight: Forecasting Global Medicine Use 

Pharma Pulse 7/14/25: Why Your Oncology Label Determines Commercial Success; How AI Teammates Will Finally Bring Us into the Modern Era

In the final part of his Pharma Commerce video interview, Marschall Runge, MD, PhD, dean of the University of Michigan Medical School and author of The Great Healthcare Disruption, details the role that academic medical centers play in shaping Medicaid policy.

A Look Under the Hood of Medicaid Support


New research finds that nearly half of the racial and ethnic disparities in outpatient COVID-19 antiviral prescriptions stem from encounter-level care barriers, such as limited access to rapid tests and telehealth, which emphasizes the need for systemic and practice-level reforms.

Study Connects COVID-19 Treatment Disparities to Gaps in Testing and Virtual Access

In the third part of this roundtable discussion, a panel of thought leaders explore the value of serialization, data sharing, and predictive analytics in identifying potential quality issues before they arise.



Peer Exchange: How Pharma Can Detect Supply Chain Failures Before They Happen (Episode 3)

Pharma Pulse 7/11/25: Removing Financial Barriers to Boost Trial Diversity; How Prescribing Power Has Shifted Beyond Physicians

Bruce Leuchter, CEO, Neurvati, explains how industry and advocacy groups can work together to ensure patient and caregiver perspectives continue to inform regulatory decisions—even without a formal public engagement pathway.

Sustaining Regulatory Engagement Through Industry and Advocacy Collaboration

Engaging the full workforce—from HR to R&D—can elevate launch outcomes, build trust, and create long-term brand ambassadors.

News